Business Ideas

Suven Life's drug discovery achieves milestone

Hyderabad-based biopharmaceutical company Suven Life Sciences Limited announced that its drug discovery collaboration in central nervous system (CNS) disorder with the US-based Eli Lilly and Company yielded a positive outcome with lead declaration leading to a milestone payment to Suven. - Suven in talks with global drug makers for licensing deal: CEO - Suven Life hits upper circuit on fund-raising plan - Suven to raise up to $20 mn through equity placement - Suven to raise Rs 241 cr for research and development - Suven Life Sciences to raise Rs 241 cr for R&D centre - Suven Life presents Alzheimer's drug data in Austria meet The milestone was achieved with the identification and selection of a first lead compound to be advanced into Lead Optimization Phase of preclinical development, Suven stated in a press release on Monday. In 2008, Suven entered into drug discovery collaboration with Eli Lilly to jointly discover and develop candidates for the treatment of CNS disorders. Under the terms of the agreement Eli Lilly will undertake the clinical development of the selected candidate/s and commercialization globally. Lilly will have the full ownership of the candidates developed under this collaboration while Suven receives ongoing research payments and preclinical milestones.This apart, the press release stated that the contract would provide substantial long-term upside for Suven through potential payments for successful milestones achieved during clinical development and royalties on worldwide sales if new drugs were commercialized. Suven scrip was trading on Bombay Stock Exchange at Rs 29.05, ip 4.87 per cent over the previous close of Rs 27.70.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

Categories
Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business
News of the day
Oil weakens in Asian trade on profit-taking
Oil fell in Asian trade today on profit-taking after overnight gains driven by hopes for improved demand as the global economy recovers, analysts said.
Popular Articles

GST Task Force advice differs from that of ministerial panel
As is now well known, the Task Force appointed by the Thirteenth Finance Commission, Government of India, has issued a report on December 15, 2009 detailing the recommendations on various issues relating to the design and implementation of the proposed GST in India.

Dual rated dual GST
The long-awaited meeting of the Empowered Committee of State Finance Ministers (EC) was recently held in Delhi and, as was perhaps expected, the EC has come out with a recommendation on what can legitimately be called a “Dual Rated Dual GST System”. There were expectations in certain quarters that the dual GST would be a single rated one at the Federal and the State level for both goods and services. This has not been possible and the EC has now come out with a dual rate model for goods. There has been no mention of whether there will be a dual rate for services as well but the understanding and expectation is that services will be taxed at just the one rate, at the Federal and State levels respectively. This article discusses the dual rate dual GST model for goods in some detail.

© Copyright 2009